We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Metformin in the Prevention of Alzheimer’s Disease and Alzheimer’s Disease Related Dementias

    Metformin is a safe and effective medication for Type 2 diabetes (T2D) that has been proposed to decrease the risk of aging related disorders...

    M. Tahmi, José A. Luchsinger in The Journal of Prevention of Alzheimer's Disease
    Article 24 October 2023
  2. Periodontal Disease and Alzheimer’s: Insights from a Systematic Literature Network Analysis

    This study investigated the relationship between periodontal disease (PD) and Alzheimer’s Disease (AD) through a Systematic Literature Network...

    Alice Villar, S. Paladini, J. Cossatis in The Journal of Prevention of Alzheimer's Disease
    Article Open access 19 April 2024
  3. Childhood obesity and risk of Alzheimer’s disease: a Mendelian randomization study

    Background

    Midlife obesity is a modifiable risk factor for Alzheimer’s disease. However, the association between childhood obesity and Alzheimer’s...

    Wenxiang Qing, Yujie Qian in Archives of Public Health
    Article Open access 18 March 2024
  4. China Alzheimer’s Disease and Neurodegenerative Disorder Research (CANDOR) -A Prospective Cohort Study for Alzheimer’s Disease and Vascular Cognitive Impairment

    Background

    Alzheimer’s disease (AD) and vascular cognitive impairment (VCI) are the two main causes of dementia. AD and VCI share similar symptoms of...

    S. Li, H. Dong, ... Jiong Shi in The Journal of Prevention of Alzheimer's Disease
    Article 29 August 2023
  5. Corneal innervation changes ın Alzheimer’s: implications for sensory dysfunction

    Purpose

    To compare, between Alzheimer’s disease (AD) patients and healthy individuals, corneal subbasal nerve plexus (CSNP) parameters and corneal...

    Ali Osman Gundogan, Refik Oltulu, ... Mehmet Okka in International Ophthalmology
    Article 24 June 2024
  6. Progress on early diagnosing Alzheimer’s disease

    Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects both cognition and non-cognition functions. The disease follows a...

    Yixin Chen, Murad Al-Nusaif, ... Weidong Le in Frontiers of Medicine
    Article 21 May 2024
  7. Mendelian Randomization Analysis Reveals Causal Factors behind Alzheimer’s Disease Risk: Evidence, Opportunities, and Challenges

    Alzheimer’s disease and its comorbidities pose a heavy disease burden globally, and its treatment remains a major challenge. Identifying the...

    X. Feng, L. Zhang, ... Lin Yang in The Journal of Prevention of Alzheimer's Disease
    Article 30 January 2024
  8. Identifying healthy individuals with Alzheimer’s disease neuroimaging phenotypes in the UK Biobank

    Background

    Identifying prediagnostic neurodegenerative disease is a critical issue in neurodegenerative disease research, and Alzheimer’s disease (AD)...

    Tiago Azevedo, Richard A. I. Bethlehem, ... Gail Li in Communications Medicine
    Article Open access 20 July 2023
  9. Association of Vascular Endothelial Growth Factor Levels with Risk of Alzheimer’s Disease: A Systematic Review and Meta-Analysis

    Background

    Alzheimer’s disease (AD) is a progressive neurodegenerative illness that leads to impairment of cognitive functions and memory loss. Even...

    Seyed Salman Zakariaee, N. Naderi, E. Azizi in The Journal of Prevention of Alzheimer's Disease
    Article 15 January 2024
  10. Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future

    Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer’s disease (AD), and its accumulation has been considered as the...

    Yun Zhang, Huaqiu Chen, ... Weihong Song in Signal Transduction and Targeted Therapy
    Article Open access 30 June 2023
  11. Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer’s Disease

    In vivo Alzheimer’s disease diagnosis and staging is traditionally based on clinical features. However, the agreement between clinical and...

    A. C. Macedo, D. F. P. A. Durço, ... Pedro Rosa-Neto in The Journal of Prevention of Alzheimer's Disease
    Article 15 January 2024
  12. Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action

    The growing prevalence and burden of Alzheimer’s disease has catalysed huge investments in research on its causes, diagnosis, treatment and care....

    Angela C. Bradshaw, J. Georges in The Journal of Prevention of Alzheimer's Disease
    Article Open access 10 February 2024
  13. Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer’s Disease in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Cohort

    Objective

    Medium-chain fatty acids (MCFAs) can rapidly cross the blood-brain barrier and provide an alternative energy source for the brain. This...

    L. Fan, X. Zhu, ... Qi Dai in The Journal of Prevention of Alzheimer's Disease
    Article 05 April 2023
  14. Fruit Intake and Alzheimer’s Disease: Results from Mendelian Randomization

    Alzheimer’s disease (AD) is the leading cause of dementia in old age, recognized as a global health priority. To explore causal effects of fresh...

    Wan-Zhe Liao, X.-F. Zhu, ... Xu-Guang Guo in The Journal of Prevention of Alzheimer's Disease
    Article 31 January 2024
  15. Cohort Effects in Alzheimer’s Disease Trials: An Empirical Assessment Utilizing Data from the Alzheimer’s Disease Cooperative Study

    Background

    Cohort effects in study populations can impact clinical trial conclusions and generalizability, particularly in trials with planned interim...

    Adam I. Birnbaum, J. D. Grill, D. L. Gillen in The Journal of Prevention of Alzheimer's Disease
    Article Open access 12 April 2023
  16. Anti-amyloid Antibody Therapies for Alzheimer’s Disease

    Alzheimer’s disease (AD) is the most common cause of dementia, which is characterized by a progressive neurodegenerative disorder that is extremely...

    Article 20 February 2024
  17. Postoperative Pain Management in Alzheimer’s Disease—a Review

    Purpose of Review

    Individuals with dementia and Alzheimer’s disease (AD) often receive inadequate analgesia compared to those without cognitive...

    Haania Shahbaz, Najwa Shakir, ... Muhammad Faizan in Current Anesthesiology Reports
    Article 29 September 2023
  18. Association between Longitudinal Cerebrospinal Fluid Alzheimer’s Biomarkers and the Lifestyle for Brain Health (LIBRA) Index: Findings from the European Prevention of Alzheimer’s Dementia Cohort Study (EPAD LCS)

    Background

    In the absence of preventative pharmacological interventions for Alzheimer’s Disease dementia, there is a growing interest in modifiable...

    Tyler S. Saunders, M. Protsiv, ... G. Muniz-Terrera in The Journal of Prevention of Alzheimer's Disease
    Article 28 March 2023
  19. The role of glial autophagy in Alzheimer’s disease

    Although Alzheimer’s disease is the most pervasive neurodegenerative disorder, the mechanism underlying its development is still not precisely...

    Anna Litwiniuk, Grzegorz Roman Juszczak, ... Kaja Urbańska in Molecular Psychiatry
    Article 07 September 2023
  20. The influence of growth and sex hormones on risk of alzheimer’s disease: a mendelian randomization study

    Alzheimer’s disease is more prevalent in women, possibly due to sex or growth hormones but existing evidence is inconclusive. We investigated whether...

    Chris Ho Ching Yeung, Shiu Lun Au Yeung, ... C. Mary Schooling in European Journal of Epidemiology
    Article 31 May 2023
Did you find what you were looking for? Share feedback.